Literature DB >> 33595644

SARS-CoV-2 Variants of Concern in the United States-Challenges and Opportunities.

Rochelle P Walensky1, Henry T Walke1, Anthony S Fauci2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33595644      PMCID： PMC9009864          DOI： 10.1001/jama.2021.2294

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   157.335


× No keyword cloud information.
  6 in total

1.  SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma.

Authors:  Constantinos Kurt Wibmer; Frances Ayres; Tandile Hermanus; Mashudu Madzivhandila; Prudence Kgagudi; Brent Oosthuysen; Bronwen E Lambson; Tulio de Oliveira; Marion Vermeulen; Karin van der Berg; Theresa Rossouw; Michael Boswell; Veronica Ueckermann; Susan Meiring; Anne von Gottberg; Cheryl Cohen; Lynn Morris; Jinal N Bhiman; Penny L Moore
Journal:  bioRxiv       Date:  2021-03-01

2.  Antibody Resistance of SARS-CoV-2 Variants B.1.351 and B.1.1.7.

Authors:  Pengfei Wang; Manoj S Nair; Lihong Liu; Sho Iketani; Yang Luo; Yicheng Guo; Maple Wang; Jian Yu; Baoshan Zhang; Peter D Kwong; Barney S Graham; John R Mascola; Jennifer Y Chang; Michael T Yin; Magdalena Sobieszczyk; Christos A Kyratsous; Lawrence Shapiro; Zizhang Sheng; Yaoxing Huang; David D Ho
Journal:  bioRxiv       Date:  2021-02-12

3.  Emergence and rapid transmission of SARS-CoV-2 B.1.1.7 in the United States.

Authors:  Nicole L Washington; Karthik Gangavarapu; Mark Zeller; Alexandre Bolze; Elizabeth T Cirulli; Kelly M Schiabor Barrett; Brendan B Larsen; Catelyn Anderson; Simon White; Tyler Cassens; Sharoni Jacobs; Geraint Levan; Jason Nguyen; Jimmy M Ramirez; Charlotte Rivera-Garcia; Efren Sandoval; Xueqing Wang; David Wong; Emily Spencer; Refugio Robles-Sikisaka; Ezra Kurzban; Laura D Hughes; Xianding Deng; Candace Wang; Venice Servellita; Holly Valentine; Peter De Hoff; Phoebe Seaver; Shashank Sathe; Kimberly Gietzen; Brad Sickler; Jay Antico; Kelly Hoon; Jingtao Liu; Aaron Harding; Omid Bakhtar; Tracy Basler; Brett Austin; Duncan MacCannell; Magnus Isaksson; Phillip G Febbo; David Becker; Marc Laurent; Eric McDonald; Gene W Yeo; Rob Knight; Louise C Laurent; Eileen de Feo; Michael Worobey; Charles Y Chiu; Marc A Suchard; James T Lu; William Lee; Kristian G Andersen
Journal:  Cell       Date:  2021-03-30       Impact factor: 41.582

4.  First Identified Cases of SARS-CoV-2 Variant B.1.1.7 in Minnesota - December 2020-January 2021.

Authors:  Melanie J Firestone; Alexandra J Lorentz; Xiong Wang; Kathryn Como-Sabetti; Sara Vetter; Kirk Smith; Stacy Holzbauer; Stephanie Meyer; Kristin Ehresmann; Richard Danila; Ruth Lynfield
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2021-02-26       Impact factor: 17.586

5.  Detection of B.1.351 SARS-CoV-2 Variant Strain - Zambia, December 2020.

Authors:  Mulenga Mwenda; Ngonda Saasa; Nyambe Sinyange; George Busby; Peter J Chipimo; Jason Hendry; Otridah Kapona; Samuel Yingst; Jonas Z Hines; Peter Minchella; Edgar Simulundu; Katendi Changula; King Shimumbo Nalubamba; Hirofumi Sawa; Masahiro Kajihara; Junya Yamagishi; Muzala Kapin'a; Nathan Kapata; Sombo Fwoloshi; Paul Zulu; Lloyd B Mulenga; Simon Agolory; Victor Mukonka; Daniel J Bridges
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2021-02-26       Impact factor: 17.586

6.  Emergence of SARS-CoV-2 B.1.1.7 Lineage - United States, December 29, 2020-January 12, 2021.

Authors:  Summer E Galloway; Prabasaj Paul; Duncan R MacCannell; Michael A Johansson; John T Brooks; Adam MacNeil; Rachel B Slayton; Suxiang Tong; Benjamin J Silk; Gregory L Armstrong; Matthew Biggerstaff; Vivien G Dugan
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2021-01-22       Impact factor: 17.586
  6 in total
  106 in total

1.  Containing novel SARS-CoV-2 variants at source is possible with high-intensity sequencing.

Authors:  Tobias S Brett; Pejman Rohani
Journal:  PNAS Nexus       Date:  2022-08-19

2.  Neutralizing antibody activity against SARS-CoV-2 variants in gestational age-matched mother-infant dyads after infection or vaccination.

Authors:  Yusuke Matsui; Lin Li; Mary Prahl; Arianna G Cassidy; Nida Ozarslan; Yarden Golan; Veronica J Gonzalez; Christine Y Lin; Unurzul Jigmeddagva; Megan A Chidboy; Mauricio Montano; Taha Y Taha; Mir M Khalid; Bharath Sreekumar; Jennifer M Hayashi; Pei-Yi Chen; G Renuka Kumar; Lakshmi Warrier; Alan Hb Wu; Dongli Song; Priya Jegatheesan; Daljeet S Rai; Balaji Govindaswami; Jordan Needens; Monica Rincon; Leslie Myatt; Ifeyinwa V Asiodu; Valerie J Flaherman; Yalda Afshar; Vanessa L Jacoby; Amy P Murtha; Joshua F Robinson; Melanie Ott; Warner C Greene; Stephanie L Gaw
Journal:  JCI Insight       Date:  2022-06-22

3.  Emergence and Spread of SARS-CoV-2 Lineages B.1.1.7 and P.1 in Italy.

Authors:  Francesca Di Giallonardo; Ilaria Puglia; Valentina Curini; Cesare Cammà; Iolanda Mangone; Paolo Calistri; Joanna C A Cobbin; Edward C Holmes; Alessio Lorusso
Journal:  Viruses       Date:  2021-04-29       Impact factor: 5.048

4.  SARS-CoV-2 B.1.1.7 and B.1.351 Spike variants bind human ACE2 with increased affinity.

Authors:  Muthukumar Ramanathan; Ian D Ferguson; Weili Miao; Paul A Khavari
Journal:  bioRxiv       Date:  2021-02-22

5.  Structural Analysis of the Novel Variants of SARS-CoV-2 and Forecasting in North America.

Authors:  Elena Quinonez; Majid Vahed; Abdolrazagh Hashemi Shahraki; Mehdi Mirsaeidi
Journal:  Viruses       Date:  2021-05-17       Impact factor: 5.048

6.  SARS-CoV-2 Spreads through Cell-to-Cell Transmission.

Authors:  Cong Zeng; John P Evans; Tiffany King; Yi-Min Zheng; Eugene M Oltz; Sean P J Whelan; Linda Saif; Mark E Peeples; Shan-Lu Liu
Journal:  bioRxiv       Date:  2021-06-01

7.  Anti-SARS-CoV-2 Antibodies Testing in Recipients of COVID-19 Vaccination: Why, When, and How?

Authors:  Giuseppe Lippi; Brandon Michael Henry; Mario Plebani
Journal:  Diagnostics (Basel)       Date:  2021-05-25

Review 8.  The Emerging Concern and Interest SARS-CoV-2 Variants.

Authors:  Edyta Janik; Marcin Niemcewicz; Marcin Podogrocki; Ireneusz Majsterek; Michal Bijak
Journal:  Pathogens       Date:  2021-05-21

Review 9.  Convalescent Plasma Therapy for COVID-19: A Graphical Mosaic of the Worldwide Evidence.

Authors:  Stephen A Klassen; Jonathon W Senefeld; Katherine A Senese; Patrick W Johnson; Chad C Wiggins; Sarah E Baker; Noud van Helmond; Katelyn A Bruno; Liise-Anne Pirofski; Shmuel Shoham; Brenda J Grossman; Jeffrey P Henderson; R Scott Wright; DeLisa Fairweather; Nigel S Paneth; Rickey E Carter; Arturo Casadevall; Michael J Joyner
Journal:  Front Med (Lausanne)       Date:  2021-06-07

10.  FnCas9-based CRISPR diagnostic for rapid and accurate detection of major SARS-CoV-2 variants on a paper strip.

Authors:  Manoj Kumar; Sneha Gulati; Asgar H Ansari; Rhythm Phutela; Sundaram Acharya; Mohd Azhar; Jayaram Murthy; Poorti Kathpalia; Akshay Kanakan; Ranjeet Maurya; Janani Srinivasa Vasudevan; Aparna S; Rajesh Pandey; Souvik Maiti; Debojyoti Chakraborty
Journal:  Elife       Date:  2021-06-09       Impact factor: 8.140
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.